Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacologic Inhibition of NT5C2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia.
Reglero C, Dieck CL, Zask A, Forouhar F, Laurent AP, Lin WW, Albero R, Miller HI, Ma C, Gastier-Foster JM, Loh ML, Tong L, Stockwell BR, Palomero T, Ferrando AA. Reglero C, et al. Among authors: miller hi. Cancer Discov. 2022 Nov 2;12(11):2646-2665. doi: 10.1158/2159-8290.CD-22-0010. Cancer Discov. 2022. PMID: 35984649 Free PMC article.
Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic Leukemia.
Rashkovan M, Albero R, Gianni F, Perez-Duran P, Miller HI, Mackey AL, Paietta EM, Tallman MS, Rowe JM, Litzow MR, Wiernik PH, Luger S, Sulis ML, Soni RK, Ferrando AA. Rashkovan M, et al. Among authors: miller hi. Cancer Discov. 2022 Mar 1;12(3):856-871. doi: 10.1158/2159-8290.CD-21-0551. Cancer Discov. 2022. PMID: 34711640 Free PMC article.
Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma.
Shih BB, Ma C, Cortes JR, Reglero C, Miller H, Quinn SA, Albero R, Laurent AP, Mackey A, Ferrando AA, Geskin L, Palomero T. Shih BB, et al. J Invest Dermatol. 2024 Jan 14:S0022-202X(23)03210-4. doi: 10.1016/j.jid.2023.12.010. Online ahead of print. J Invest Dermatol. 2024. PMID: 38219917 Free article.
RuBi-Ruxolitinib: A Photoreleasable Antitumor JAK Inhibitor.
Rafic E, Ma C, Shih BB, Miller H, Yuste R, Palomero T, Etchenique R. Rafic E, et al. J Am Chem Soc. 2024 May 15;146(19):13317-13325. doi: 10.1021/jacs.4c01720. Epub 2024 May 3. J Am Chem Soc. 2024. PMID: 38700457
COVID-19 Testing Tests Our Mettle.
Hefferon KL, St Juliana JR, Miller HI. Hefferon KL, et al. Among authors: miller hi. Mo Med. 2020 Sep-Oct;117(5):417-420. Mo Med. 2020. PMID: 33311741 Free PMC article. No abstract available.
Flawed scientific studies block progress and sow confusion.
Hefferon KL, Miller HI. Hefferon KL, et al. Among authors: miller hi. GM Crops Food. 2020 Jul 2;11(3):125-129. doi: 10.1080/21645698.2020.1737482. Epub 2020 Mar 10. GM Crops Food. 2020. PMID: 32154759 Free PMC article.
296 results